Circulating tumor DNA analysis for patients with oncogene-addicted NSCLC with isolated central nervous system progression
Literature
Read More
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
Literature
Read More
Analysis of Real-World PD-L1 Testing and PD-L1 IHC 28-8 and 22C3 Assay Concordance in Patients with Breast Cancer
Literature
Read More
NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization
Press Release
Read More
NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference
Press Release
Read More
NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter
Press Release
Read More
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2019 Earnings Release for February 27, 2020
Press Release
Read More